| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |